Cost-effectiveness of sacral neuromodulation compared to botulinum neurotoxin a or continued medical management in refractory overactive bladder

  1. Arlandis, S.
  2. Castro, D.
  3. Errando, C.
  4. Fernández, E.
  5. Jiménez, M.
  6. González, P.
  7. Crespo, C.
  8. Staeuble, F.
  9. Rodríguez, J.M.
  10. Brosa, M.
Revista:
Value in Health

ISSN: 1524-4733 1098-3015

Any de publicació: 2011

Volum: 14

Número: 2

Pàgines: 219-228

Tipus: Article

DOI: 10.1016/J.JVAL.2010.08.006 GOOGLE SCHOLAR lock_openAccés obert editor